Don't Just Read the News, Understand It.
Published loading...Updated

Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly

  • Ro is working to make weight loss drug Zepbound more affordable
  • The collaboration with Eli Lilly aims to achieve this goal
  • Ro and Eli Lilly focus on offering lower-price vials
Insights by Ground AI
Does this summary seem wrong?

11 Articles

All
Left
Center
4
Right
1
Lean Right

Eli Lilly will start offering vials of her best-selling weight loss drug, Zepbound, through Ro's telehealth platform this Wednesday, providing patients with another way to access a more affordable version of the injection. Previously, patients could only get vials of Zepbound, which are normally sold in a self-injecting pen, through Lilly's direct-sell site to Lilly's consumer, LillyDirect. To reinforce the supplies of popular drugs amid a natio…

·Mexico
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 80% of the sources are Center
80% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Quartz broke the news in United States on Wednesday, December 11, 2024.
Sources are mostly out of (0)